INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

INABIN8BIO, INC.

CIK 0001740279

EDGAR filingsOpen in network
Disclosed transactions11
Buys / sells0 / 0
Max Insider Score21
Connections7with evidence

INAB · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
GL
Greenwood LubaDirector
INABIN8BIO, INC.
Grant or award
A—
22.0K sh
May 9, 2026May 12, 2026
traded May 9, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Graff Jeremy R.Director · May 12, 2026
  • ← Insider ofevidence
    Greenwood LubaDirector · May 12, 2026
  • ← Insider ofevidence
    Lamb LawrenceEVP and CSO · Feb 6, 2026
  • ← Insider ofevidence
9
GR
Graff Jeremy R.Director
INABIN8BIO, INC.
Grant or award
A
—
22.0K sh
May 9, 2026
May 12, 2026
traded May 9, 2026
+3d
SEC FORM 4

Evidence

9
RK
Rochlin KatePresident and COO
INABIN8BIO, INC.
Grant or award
A—
60.0K sh
May 9, 2026May 12, 2026
traded May 9, 2026
+3dSEC FORM 4

Evidence

9
MP
McCall PatrickCHIEF FINANCIAL OFFICER
INABIN8BIO, INC.
Grant or award
A—
56.3K sh
May 9, 2026May 12, 2026
traded May 9, 2026
+3dSEC FORM 4

Evidence

9
HW
Ho William Tai-WeiDirector, CEO, 10% Owner
INABIN8BIO, INC.
Grant or award
A—
206.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

9
MP
McCall PatrickCHIEF FINANCIAL OFFICER
INABIN8BIO, INC.
Grant or award
A—
75.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

9
RK
Rochlin KatePresident and COO
INABIN8BIO, INC.
Grant or award
A—
80.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

9
LL
Lamb LawrenceEVP and CSO
INABIN8BIO, INC.
Grant or award
A—
72.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

20
HW
Ho William Tai-WeiDirector, PRESIDENT AND CEO, 10% Owner
INABIN8BIO, INC.
Grant or award
A$50K
36.2K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

21
RK
Rochlin KateChief Operating Officer
INABIN8BIO, INC.
Grant or award
A$10K
7,247 sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

21
MP
McCall PatrickCHIEF FINANCIAL OFFICER
INABIN8BIO, INC.
Grant or award
A$10K
7,247 sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

McCall Patrick
CHIEF FINANCIAL OFFICER · Dec 23, 2025
  • ← Insider ofevidence
    Rochlin KateChief Operating Officer · Dec 23, 2025
  • ← Insider ofevidence
    Ho William Tai-WeiDirector, PRESIDENT AND CEO, 10% Owner · Dec 23, 2025